Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.790965
Title: Development of human induced pluripotent stem cell derived kidney organoids for disease modelling of diabetic nephropathy with chemical mediators and CRISPR-Cas9 genome editing
Author: Dalliston, Thomas William Mark
ISNI:       0000 0004 8500 2901
Awarding Body: UCL (University College London)
Current Institution: University College London (University of London)
Date of Award: 2019
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
Diabetic nephropathy (DN) is a leading cause of morbidity and mortality worldwide, yet current disease models are failing to meet the need for new efficacious drugs. Kidney organoids differentiated from human induced pluripotent stem cells (hiPSCs) have recapitulated much of the kidney's structural complexity, but currently reach only foetal-like maturity. Organ specific extracellular matrix (ECM) has been shown to promote differentiation and maturation of relevant cell types. Therefore, we aimed to create a three dimensional (3D), decellularised human kidney ECM-gel (K-gel) based kidney organoid differentiation system. We aimed to demonstrate the utility of the system for DN modelling by exposing the organoids to disease mediators (including hyperglycemia, angiotensin II and TGF-β), and through growth of organoids from hiPSCs modified with CRIPSR-Cas9 at genes linked to DN (UMOD and TIMP3). HiPSC derived kidney organoids differentiated in a Matrigel®-based 3D sandwich system showed segmented 3D expression of mature nephron markers and had the ability to uptake dextran at functional proximal tubular transporters. Initial differentiations using decellularised kidney ECM-hydrogel (K-gel) were unsuccessful in deriving typical organoids. Human kidneys decellularised by perfusion, with SDS, ddH2O and NaCl, proved more successful than immersion protocols for removal of DNA and preservation of ECM and renal microarchitecture. K-gel was able to form solidified layers and support hiPSC growth. TIMP3 and UMOD knock-out CRISPR-Cas9 plasmids were created, but genetically modified hiPSC lines were not achieved. Kidney organoids exposed to disease mediators displayed a DN specific gene expression profile of NOTCH1 upregulation concomitant with NOTCH3 downregulation; but did not show a robust fibrosis or EMT gene expression profile. With further refinement the protocols developed herein will enable the modelling of DN, or other kidney diseases, in an in vitro 3D renal organoid model generated through differentiation of hiPSCs in a decellularised human kidney derived ECM gel-based system.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.790965  DOI: Not available
Share: